Table: Peptidream - 6-MTH parent results
Feb 13 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Dec 31, 2017 Dec 31, 2016 Jun 30, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 913 mln 1.16
(-21.5 pct) (+12.5 pct)
Operating loss 895 mln 345 mln
(-5.9 pct)
Recurring loss 764 mln 499 mln
(+37.4 pct)
Net loss 534 mln 350 mln
(+42.0 pct)
EPS loss 4.49 yen 3.07 yen
EPS Diluted 2.70 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner